Form D Explorer
OrbitalRx, Inc. · CIK 1740062

Report a data issueCitable research briefCompare issuerPrivate research collection

OrbitalRx, Inc.

CIK 1740062 · Corporation · Inc. DELAWARE · WINSTON-SALEM, North Carolina · Other Technology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Mar 5, 2025
through Oct 20, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMar 5, 2025 · DOct 20, 2025 · DLater minus earlier
Reported offering amount$1,250,000$2,500,000$1,250,000
Reported amount sold$958,932$1,224,329$265,397
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001740062-25-000001 · Later SEC source: 0001740062-25-000003

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Oct 20, 2025

Reported offering amount
$2,500,000
Reported exemptions
Rule 506(b)
Reported amount sold
$1,224,329

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Related person name and locality match

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Form D filings (2)